Alexandre Gross

Person

Jersey City, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heteroaryl compounds and uses thereof
- Patent number 10,774,052
- Issue date Sep 15, 2020
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
- Patent number 10,618,902
- Issue date Apr 14, 2020
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds and uses thereof
- Patent number 10,189,794
- Issue date Jan 29, 2019
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
- Patent number 10,065,966
- Issue date Sep 4, 2018
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds and uses thereof
- Patent number 9,695,132
- Issue date Jul 4, 2017
- Celgene CAR LLC
- Laura Akullian D'Agostino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors
- Patent number 9,663,524
- Issue date May 30, 2017
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds and uses thereof
- Patent number 9,321,786
- Issue date Apr 26, 2016
- Celgene Avilomics Research, Inc.
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as P2X7 ion channel blockers
- Patent number 7,741,493
- Issue date Jun 22, 2010
- Aventis Pharmaceuticals Inc.
- Patrick Shum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazoles as inhibitors of tumor necrosis factor
- Patent number 7,541,368
- Issue date Jun 2, 2009
- Aventis Pharmaceuticals Inc.
- David Roger Borcherding
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as P2X7 ion channel blockers
- Patent number 7,326,792
- Issue date Feb 5, 2008
- Aventis Pharmaceuticals Inc.
- Patrick Shum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives as interleukin-4 gene expression inhibitors
- Patent number 7,169,925
- Issue date Jan 30, 2007
- Aventis Pharmaceuticals Inc.
- Gregory H. Merriman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INDOLE COMPOUNDS AND METHODS OF USE
- Publication number 20240279220
- Publication date Aug 22, 2024
- Genzyme Corporation
- Junkai Liao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLE COMPOUNDS AND METHODS OF USE
- Publication number 20240239784
- Publication date Jul 18, 2024
- Genzyme Corporation
- Junkai Liao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20220332687
- Publication date Oct 20, 2022
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20190375719
- Publication date Dec 12, 2019
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20190218220
- Publication date Jul 18, 2019
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20180022713
- Publication date Jan 25, 2018
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20170267685
- Publication date Sep 21, 2017
- Celgene CAR LLC
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20160221966
- Publication date Aug 4, 2016
- Celgene Avilomics Research, Inc.
- Laura Akullian D'Agostino
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20160046634
- Publication date Feb 18, 2016
- CELGENE AVILOMICS RESEARCH, INC.
- Laura Akullian D'Agostino
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AND USES THEREOF
- Publication number 20140296233
- Publication date Oct 2, 2014
- SANOFI
- Laura Akullian D'Agostino
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETEROCYCLIC COMPOUNDS AS P2X7 ION CHANNEL BLOCKERS
- Publication number 20080132550
- Publication date Jun 5, 2008
- Aventis Pharmaceuticals Inc.
- Patrick SHUM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrazoles as inhibitors of tumor necrosis factor
- Publication number 20060063796
- Publication date Mar 23, 2006
- Aventis Pharmaceuticals Inc.
- David R. Borcherding
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic compounds as P2X7 ion channel blockers
- Publication number 20050026916
- Publication date Feb 3, 2005
- Aventis Pharmaceuticals Inc.
- Patrick Shum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Indole derivatives as interleukin -4 gene expression inhibitors
- Publication number 20040010029
- Publication date Jan 15, 2004
- Gregory H. Merriman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Alexandre Gross

Person

Patents Grantslast 30 patents

Heteroaryl compounds and uses thereof

Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases

Heteroaryl compounds and uses thereof

Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases

Heteroaryl compounds and uses thereof

Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors

Heteroaryl compounds and uses thereof

Heterocyclic compounds as P2X7 ion channel blockers

Pyrazoles as inhibitors of tumor necrosis factor

Heterocyclic compounds as P2X7 ion channel blockers

Indole derivatives as interleukin-4 gene expression inhibitors

Patents Applicationslast 30 patents

INDOLE COMPOUNDS AND METHODS OF USE

INDOLE COMPOUNDS AND METHODS OF USE

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AND USES THEREOF

HETEROCYCLIC COMPOUNDS AS P2X7 ION CHANNEL BLOCKERS

Pyrazoles as inhibitors of tumor necrosis factor

Heterocyclic compounds as P2X7 ion channel blockers

Indole derivatives as interleukin -4 gene expression inhibitors